Building Arizona as a global center for research and commercialization in the biosciences and a leader in such areas as precision medicine.
The Flinn Foundation supports the biosciences in Arizona through research grants and stewardship of Arizona’s Bioscience Roadmap, released in 2002 and guiding the growth and development of the state’s bioscience sector through 2025.
The Roadmap’s tagline, “Advancing the Biosciences and Improving Health Outcomes” recognizes the broad spectrum of the biosciences, including research, academia, and product commercialization, as well as the central role of health care within the bioscience sector.
Celgene, which has operated a biopharmaceutical manufacturing plant in Phoenix for nearly a decade, has been acquired by Bristol-Myers Squibb for about $74 billion, a merger that creates a global biopharma company with a focus on patients with cancer, inflammatory and immunologic disease, and cardiovascular disease.
Janet Spear, plant manager for Celgene’s facility in Phoenix, serves on Arizona’s Bioscience Roadmap Steering Committee, a group with more than 100 Arizona bioscience leaders from the public and private sectors in science, health care, business, academia, and policy that helps oversee Arizona’s Bioscience Roadmap. [Read more]
The Flinn Foundation has surpassed $1 million in funding support to benefit Arizona bioscience startup companies with the selection of six firms to participate in the foundation’s 2019 Bioscience Entrepreneurship Program.
In addition to $30,000 in funding administered through a nonprofit partner, the entrepreneurship program provides each competitively selected firm a bundle of benefits, including a professionally developed, yearlong plan specific to the needs of the company, helping them to navigate the challenges facing startups and empowering them to become investor-ready. [Read more]
Stay up to date. Join our email list.
C-Path picks global regulatory affairs leader as new CEO / AZ Big Media After a worldwide search, Tucson-based Critical Path Institute has appointed Joseph Scheeren, Pharm. D., as its new President and Chief Executive Officer. Scheeren previously served in senior roles for Bayer AG and has had a distinguished 36-year career in drug development and […]
Phoenix focuses on bioscience with groundbreaking of biomedical campus downtown / KJZZ Christine Mackay, community and economic development director with the city of Phoenix, speaks about Wexford Science & Technology LLC’s groundbreaking of a new 200,000-square-foot research center on the Phoenix Biomedical Campus, to be anchored by Arizona State University, and the region’s growing bioscience […]
How Wexford’s $77M research facility in downtown Phoenix came to fruition / Phoenix Business Journal Wexford Science & Technology LLC, which works with universities, medical centers and research institutions to create innovation and entrepreneurial activity, breaks ground on a $77 million, 200,000-square-foot research center on the north side of the Phoenix Biomedical Campus that will […]
The Flinn Foundation has surpassed $1 million in funding support to benefit Arizona bioscience startup companies with the selection of six firms to participate in the foundation’s 2019 Bioscience Entrepreneurship Program. The Flinn Foundation has selected 34 Arizona bioscience firms since 2014 to participate in the program, which was created to foster entrepreneurship and further […]